Notably, semaglutide reduced the levels of several proteins previously reported to be elevated in HFpEF patients, such as IFN-, IL-17B, DLL1, TNFRSF11B, and TREM-2 ( Figure 2G ) 5862
Both additives address common patient experiences during GLP-1 therapy: reduced energy from caloric deficit, and the desire to support active fat metabolism
other GLP-1s side effect comparison What we dont know yet: Long-term safety The phase 2 clinical trials show promising results for retatrutide
Some patients experience occasional nausea weeks even in months 4-6, particularly the day after injection or after fatty meals
The injectable version is administered once weekly via subcutaneous injection, following the same general semaglutide protocol used with brand-name medications
Despite the progress, the publications by Holst's team indicate that they did not yet know the entire amino acid sequence of the porcine peptide